Pharmaxis Overview

  • Founded
  • 1998
Founded
  • Status
  • Public
  • Employees
  • 93
Employees
  • Stock Symbol
  • PXS
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $0.07
  • (As of Monday Closing)

Pharmaxis General Information

Description

Pharmaxis Ltd is an Australia based pharmaceutical research company engaged in the research, development, and commercialization of human healthcare products for the treatment and management of fibrotic and inflammatory diseases. The firm's research efforts are focused on discovering drugs to treat inflammatory and fibrotic diseases such as NASH, pulmonary fibrosis, kidney and liver fibrosis and cancer from its amine oxidase inhibitor chemistry platform. Its product pipeline also includes Orbital and ASM8. The operating segments of the group are Mannitol business and New Drug Development.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
ASX
Primary Office
  • Locked Bag 5015
  • Frenchs Forest, New South Wales 2086
  • Australia
+61 (02) 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmaxis Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.07 $0.07 $0.04 - $0.12 $30.2M 452M 715K

Pharmaxis Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 19,950 21,155 46,277 60,116
Revenue 4,714 4,707 4,058 5,641
EBITDA (1,894) (8,862) (12,949) 7,541
Net Income (2,461) (9,339) (14,342) 4,979
Total Assets 25,214 24,335 36,885 36,801
Total Debt 5,581 5,603 5,022 6,074
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pharmaxis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharmaxis‘s full profile, request access.

Request a free trial

Pharmaxis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Pharmaxis Ltd is an Australia based pharmaceutical research company engaged in the research, development, and commercial
Pharmaceuticals
Frenchs Forest, Australia
93 As of 2009
00000
000000000 00000

000000 0

aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. E
000000000000000
Norwood, MA
00 As of 0000
00.00
0000000000 00.00

00000000

ate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proiden
0000000000000
Calgary, Canada
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pharmaxis Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Corbus Pharmaceuticals Formerly VC-backed Norwood, MA 00 00.00 0000000000 00.00
00000000000 Corporation Calgary, Canada 00 00000 000000000 00000
000000000 Venture Capital-Backed Atlanta, GA 00 000.00 00000000000 000.00
0000000000000 0000 Formerly VC-backed Cambridge, MA 000 00000 000000 - 000 00000
000000 0000000000 Venture Capital-Backed Tucson, AZ 00 000.00 0000000000 0 000.00
You’re viewing 5 of 14 competitors. Get the full list »

Pharmaxis Executive Team (2)

Name Title Board Seat Contact Info
Gary Phillips Chief Executive Officer & Board Member
David McGarvey Chief Financial Officer & Company Secretary
To view Pharmaxis’s complete executive team members history, request access »

Pharmaxis Board Members (5)

Name Representing Role Since
Gary Phillips Pharmaxis Chief Executive Officer & Board Member 000 0000
Malcolm McComas Pharmaxis Independent Chairman 000 0000
Neil Graham Pharmaxis Board Member 000 0000
William Delaat Self Non-Executive Director 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Pharmaxis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharmaxis Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pharmaxis‘s full profile, request access.

Request a free trial

Pharmaxis Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 0000000 26-May-2010 000000000000000000 00.000 Medical Supplies
Topigen Pharmaceuticals 09-Feb-2010 Merger/Acquisition 00.000 Drug Discovery
To view Pharmaxis’s complete acquisitions history, request access »